CeriBell, Inc. (CBLL) is a Medical devices company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for CeriBell, Inc. in 2026. The next earnings report is expected on November 17, 2026.
Next earnings date
17 Nov 2026
In 89 days
EPS estimate
-0.38
Revenue estimate
28.8M
Past earnings
Latest earnings analysis
CeriBell, Inc. missed consensus estimates on EPS but revenue came in above expectations in its latest earnings report, with EPS of -$0.51 versus an estimate of -$0.4712 and revenue of $28.1 million, 3.0% above expectations. In the previous report EPS also missed expectations while revenue came in ahead of estimates.
No dividend history available.
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
CeriBell, Inc. (CBLL) is scheduled to report earnings on November 17, 2026.
CeriBell, Inc. (CBLL) last reported earnings on August 10, 2026.
CeriBell, Inc. (CBLL) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.